Featured in Chronic Spontaneous Urticaria (CSU)
Fast Relief, Sustained Control: What Remibrutinib Shows in CSU
Discover this week's featured video and expert opinion
Latest Chronic Spontaneous Urticaria (CSU) Videos
Chronic Spontaneous Urticaria (CSU)
Early Response, Sustained Control: 52-Week Outcomes With Remibrutinib
Featuring Nicholas Brownstone, MD
Chronic Spontaneous Urticaria (CSU)
Advances and Applications in Chronic Spontaneous Urticaria Care
Featuring Naiem Issa, MD, PhD, FAAD | Dawn Merritt, DO
Featured CME on Chronic Spontaneous Urticaria (CSU)
Chronic Spontaneous Urticaria (CSU) Episodes to Explore
Episode 119
Chronic Hives Are Back! New Perspectives on Evaluation and Management
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, sits down with Jason Hawkes, MD, Chief Scientific Officer...
Episode 78
Improving Your Clinical Approach To Chronic Urticaria
In this episode of Derms and Conditions, host James Q Del Rosso, DO, engages in a comprehensive discussion with Jason Hawkes, MD,...
Chronic Spontaneous Urticaria (CSU) News & Research
FDA Approves Dupixent for Chronic Spontaneous Urticaria in Young Children
The expanded indication is for children ages 2 to 11 years who remain symptomatic despite histamine-1 antihistamine treatment
Study Compares Benefits, Harms of Treatments for Chronic Hives
Systematic review and network meta-analysis included 93 trials evaluating 42 interventions
Urticaria Reported in Trial of Investigational HIV mRNA Vaccines
7 percent of 108 healthy volunteers reported urticaria; unresolved urticaria persisted at 12 months in four participants